Who is sponsoring NCT06748534?

NCT06748534 is sponsored by Superior University.

What drugs are being tested in NCT06748534?

Interventions in NCT06748534: Plus Lens Addition (+0.75 D), Vision Therapy Using HART Chart.

What condition does NCT06748534 study?

NCT06748534 studies Accommodative Insufficiency.

Is NCT06748534 still recruiting?

NCT06748534 is currently active, enrolled. Last updated 27 December 2024.

Last reviewed 2024-12-27 · How we verify

NCT06748534

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Plus Lens Addition Versus Vision Therapy for Management of Accommodative Infacility

Active, enrolled NA Last updated 27 December 2024

What this trial tests

NA trial testing Plus Lens Addition (+0.75 D) in Accommodative Insufficiency in 38 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 March 2024

Primary endpoint
1 August 2024

28 February 2025

Quick facts

Lead sponsor	Superior University
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	38
Start date	1 March 2024
Primary completion	1 August 2024
Estimated completion	28 February 2025
Sites	1 location across Pakistan

Drugs / interventions tested

Plus Lens Addition (+0.75 D)
Vision Therapy Using HART Chart

Conditions studied

Accommodative Insufficiency — all drugs for Accommodative Insufficiency →

Sponsor

Superior University

Who can join

Adults 15 to 35, any sex, with Accommodative Insufficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This Randomized Control Trials Study , conducted in Lahore, Pakistan, investigates the comparative efficacy of two approaches-plus lens addition of +0.75 diopters (D) and vision therapy using the HART chart-for managing accommodative infacility. Accommodative infacility, a condition characterized by the eye's reduced ability to adjust focus between distant and near objects, impacts both visual comfort and performance, particularly during prolonged near work.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Superior University trials

Trials by the same sponsor.

NCT07521839 — Title of This Study is to Evaluate the Effects of Abdominal Drawing in Maneuver With Cross Pattern Limb Exercises in Pat · NA · active not recruiting
NCT07523425 — Collaborative vs Non-Immersive VR in Parkinson's Rehabilitation · NA · recruiting
NCT07068347 — Comparison Of VR & CPT, With And Without Lifestyle Modification, On ULD In Breast Cancer Survivors · NA · active not recruiting
NCT07336459 — AI-Driven MRF Type 2 Diabetes Integrating DHT IF and Resistance Training to OM and Functional Outcomes · NA · active not recruiting
NCT07385066 — Effects of (tDCS) Combined With Virtual Reality Versus CPT on Brain, Cognitive, and GMS in Children With DS. · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06748534 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Superior University
Last refreshed: 27 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06748534.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing